Literature DB >> 12782093

Type B brevetoxins show tissue selectivity for voltage-gated sodium channels: comparison of brain, skeletal muscle and cardiac sodium channels.

Marie-Yasmine Bottein Dechraoui1, John S Ramsdell.   

Abstract

Brevetoxins and ciguatoxins are two classes of phycotoxins which exert their toxic effect by binding to site-5 of voltage-gated sodium channels. Sodium channels, a family of at least 10 structurally different proteins, are responsible for the rising phase of the action potential in membranes of neuronal, cardiac and muscular excitable cells. This work is a comparative study of the binding properties and the cytotoxic effects of ciguatoxins and brevetoxins on human embryonic cells (HEK) stably expressing either the skeletal muscle (Na(v)1.4), or the cardiac (Na(v)1.5) sodium channel alpha-subunit isoforms. We report that type A (PbTx-1) and type B (PbTx-3 and PbTx-2) brevetoxins as well as ciguatoxins target both cardiac and muscle channels; type B brevetoxins show isoform selectivity, presenting a lower affinity for the heart than the skeletal muscle channel. The lower selectivity of type B brevetoxins for heart sodium channels may result from a more rigid backbone structure than is found in type A brevetoxins and ciguatoxins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782093     DOI: 10.1016/s0041-0101(03)00088-6

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  14 in total

Review 1.  Voltage-gated Na+ channels: multiplicity of expression, plasticity, functional implications and pathophysiological aspects.

Authors:  J K J Diss; S P Fraser; M B A Djamgoz
Journal:  Eur Biophys J       Date:  2004-02-12       Impact factor: 1.733

Review 2.  Update on methodologies available for ciguatoxin determination: perspectives to confront the onset of ciguatera fish poisoning in Europe.

Authors:  Amandine Caillaud; Pablo de la Iglesia; H Taiana Darius; Serge Pauillac; Katerina Aligizaki; Santiago Fraga; Mireille Chinain; Jorge Diogène
Journal:  Mar Drugs       Date:  2010-06-14       Impact factor: 5.118

3.  Airway responses to aerosolized brevetoxins in an animal model of asthma.

Authors:  William M Abraham; Andrea J Bourdelais; Juan R Sabater; Ashfaq Ahmed; Troy A Lee; Irakli Serebriakov; Daniel G Baden
Journal:  Am J Respir Crit Care Med       Date:  2004-09-24       Impact factor: 21.405

4.  A quantitative and comparative study of the effects of a synthetic ciguatoxin CTX3C on the kinetic properties of voltage-dependent sodium channels.

Authors:  Kaoru Yamaoka; Masayuki Inoue; Hidemichi Miyahara; Keisuke Miyazaki; Masahiro Hirama
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

Review 5.  Phytoplankton Toxins and Their Potential Therapeutic Applications: A Journey toward the Quest for Potent Pharmaceuticals.

Authors:  Biswajita Pradhan; Jang-Seu Ki
Journal:  Mar Drugs       Date:  2022-04-18       Impact factor: 6.085

6.  Distribution of brevetoxin (PbTx-3) in mouse plasma: association with high-density lipoproteins.

Authors:  Ricky T Woofter; Page C Spiess; John S Ramsdell
Journal:  Environ Health Perspect       Date:  2005-11       Impact factor: 9.031

7.  The type B brevetoxin (PbTx-3) adversely affects development, cardiovascular function, and survival in Medaka (Oryzias latipes) embryos.

Authors:  Jamie R Colman; John S Ramsdell
Journal:  Environ Health Perspect       Date:  2003-12       Impact factor: 9.031

Review 8.  Ladder-Shaped Ion Channel Ligands: Current State of Knowledge.

Authors:  Yuri B Shmukler; Denis A Nikishin
Journal:  Mar Drugs       Date:  2017-07-20       Impact factor: 5.118

9.  Interaction of a dinoflagellate neurotoxin with voltage-activated ion channels in a marine diatom.

Authors:  Sheila A Kitchen; Andrea J Bourdelais; Alison R Taylor
Journal:  PeerJ       Date:  2018-04-03       Impact factor: 2.984

10.  Evaluation of Matrix Issues in the Applicability of the Neuro-2a Cell Based Assay on the Detection of CTX in Fish Samples.

Authors:  David Castro; Ronald Manger; Oscar Vilariño; Ana Gago-Martínez
Journal:  Toxins (Basel)       Date:  2020-05-09       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.